Targeting Cancer Pathways - Tumor Resistance


Posted by Carolyn P on Oct 18, 2017 6:00:00 AM


Cell Signaling Technology is proud to partner with the Koch Institute at MITScience, and Science Signaling to present the Targeting Cancer Pathways webinar series. These webinars bring together thought leaders from around the world to share current findings and further cancer research community collaboration.

In this webinar the speakers examine how rewiring of signaling pathways in response to drug treatment contributes to tumor resistance and how this knowledge can inform the development of more effective treatment strategies.

Featured Speakers:

yaffe_1_mod

Michael B. Yaffe, M.D., Ph.D.
Massachusetts Institute of Technology, Cambridge, MA

jeffrey_engelman_mod

Jeffrey Engelman, M.D., Ph.D.
Harvard Medical School, Boston, MA

deininger_1_mod

Michael W. Deininger, M.D., Ph.D.
University of Utah, Salt Lake City, UT
 
Watch Now
 

 Watch more webinars available on-demand on our Videos and Webinars page.

 

  CancerPoster2013-sm5